Proteomic profiling shows progressive inflammation and tissue remodeling in ovaries decades after menopause

Northwestern and Buck Institute researchers used mass spectrometry proteomics on postmortem or surgical ovarian samples to compare women in their 50s versus those 70 and older. They documented sustained remodeling, loss of original cellular identity, and molecular signatures previously linked to ovarian cancer risk. These changes occurred independently of hormone production, which had already ceased. The work extends earlier mouse findings and reframes the ovary as an active participant in systemic aging rather than a quiescent remnant.

Prior observational studies on postmenopausal health focused on circulating hormones or abrupt surgical menopause effects, missing the gradual proteomic shifts now quantified here. The current data suggest the ovary may influence distant tissues via inflammatory mediators, potentially contributing to accelerated bone loss and cognitive changes after age 70. Human tissue scarcity limited sample size, and the cross-sectional design cannot establish causality or directionality of effects.

Future longitudinal studies must track the same women with serial imaging and biomarker panels to test whether ovarian proteomic signatures predict clinical outcomes such as fracture incidence or cardiovascular events. Removal of healthy ovaries in low-risk women would require evidence that late-life ovarian activity becomes net harmful, a threshold not yet demonstrated.